Cargando…

Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas

BACKGROUND: Malignant bone lymphoma can be classified as primary (PBL) or secondary (SBL) bone lymphoma. However, the clinico-pathological characteristics and prognostic factors of PBL versus SBL have not yet been well defined. Whether lymphoma with multifocal bone involvement should be considered a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Huanwen, Bui, Marilyn M, Leston, Douglas G, Shao, Haipeng, Sokol, Lubomir, Sotomayor, Eduardo M, Zhang, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265495/
https://www.ncbi.nlm.nih.gov/pubmed/25465716
http://dx.doi.org/10.1186/1471-2407-14-900
_version_ 1782348900480319488
author Wu, Huanwen
Bui, Marilyn M
Leston, Douglas G
Shao, Haipeng
Sokol, Lubomir
Sotomayor, Eduardo M
Zhang, Ling
author_facet Wu, Huanwen
Bui, Marilyn M
Leston, Douglas G
Shao, Haipeng
Sokol, Lubomir
Sotomayor, Eduardo M
Zhang, Ling
author_sort Wu, Huanwen
collection PubMed
description BACKGROUND: Malignant bone lymphoma can be classified as primary (PBL) or secondary (SBL) bone lymphoma. However, the clinico-pathological characteristics and prognostic factors of PBL versus SBL have not yet been well defined. Whether lymphoma with multifocal bone involvement should be considered as stage IV PBL or SBL still remain controversial throughout the literature. METHODS: In this study, we retrospectively reviewed 127 patients with bone lymphoma diagnosed from1998 to 2013 at the Moffitt Cancer Center. Patients were classified as PBL (81 cases) and SBL (46 cases) using the 2013 WHO Classification of Bone/Soft Tissue Tumors and PBL patients were further subdivided into: 1) PBL with unifocal bone disease (uPBL, 46 cases), 2) PBL with multifocal bone involvement (mPBL, 35 cases). Patient characteristics, survival, and prognostic factors were analyzed. RESULTS: Diffuse large B-cell lymphoma (DLBCL) was the most common histological subtype in all three groups (37/46 of uPBL, 23/35 of mPBL, 23/46 of SBL). B symptoms, lymph node involvement, and bone marrow involvement were found to be more common in mPB-DLBCL and SB-DLBCL groups than in the uPB-DLBCL group. Femur was found to be the most common affected site in uPB-DLBCL patients, while spine was most commonly involved in the other two groups. Survival analysis indicated that uPBL-DLBCL patients had a significantly better progression-free survival (PFS) and overall survival (OS) than those in the other two groups (P < 0.05). We also found by univariate analysis that multifocality, and stage IV were significantly poor prognostic factors for both PFS and OS in PBL patients. Using multivariate analysis, multifocality remained an independent prognostic factor for both PFS and OS (P = 0.0117, RR: 3.789, 95% CI: 1.275-11.256). CONCLUSION: Overall, our results suggest that mPBL is more similar to SBL in characteristics and survival rather than uPBL, and thus should be better classified and treated as SBL. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-900) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4265495
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42654952014-12-15 Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas Wu, Huanwen Bui, Marilyn M Leston, Douglas G Shao, Haipeng Sokol, Lubomir Sotomayor, Eduardo M Zhang, Ling BMC Cancer Research Article BACKGROUND: Malignant bone lymphoma can be classified as primary (PBL) or secondary (SBL) bone lymphoma. However, the clinico-pathological characteristics and prognostic factors of PBL versus SBL have not yet been well defined. Whether lymphoma with multifocal bone involvement should be considered as stage IV PBL or SBL still remain controversial throughout the literature. METHODS: In this study, we retrospectively reviewed 127 patients with bone lymphoma diagnosed from1998 to 2013 at the Moffitt Cancer Center. Patients were classified as PBL (81 cases) and SBL (46 cases) using the 2013 WHO Classification of Bone/Soft Tissue Tumors and PBL patients were further subdivided into: 1) PBL with unifocal bone disease (uPBL, 46 cases), 2) PBL with multifocal bone involvement (mPBL, 35 cases). Patient characteristics, survival, and prognostic factors were analyzed. RESULTS: Diffuse large B-cell lymphoma (DLBCL) was the most common histological subtype in all three groups (37/46 of uPBL, 23/35 of mPBL, 23/46 of SBL). B symptoms, lymph node involvement, and bone marrow involvement were found to be more common in mPB-DLBCL and SB-DLBCL groups than in the uPB-DLBCL group. Femur was found to be the most common affected site in uPB-DLBCL patients, while spine was most commonly involved in the other two groups. Survival analysis indicated that uPBL-DLBCL patients had a significantly better progression-free survival (PFS) and overall survival (OS) than those in the other two groups (P < 0.05). We also found by univariate analysis that multifocality, and stage IV were significantly poor prognostic factors for both PFS and OS in PBL patients. Using multivariate analysis, multifocality remained an independent prognostic factor for both PFS and OS (P = 0.0117, RR: 3.789, 95% CI: 1.275-11.256). CONCLUSION: Overall, our results suggest that mPBL is more similar to SBL in characteristics and survival rather than uPBL, and thus should be better classified and treated as SBL. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-900) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-02 /pmc/articles/PMC4265495/ /pubmed/25465716 http://dx.doi.org/10.1186/1471-2407-14-900 Text en © Wu et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wu, Huanwen
Bui, Marilyn M
Leston, Douglas G
Shao, Haipeng
Sokol, Lubomir
Sotomayor, Eduardo M
Zhang, Ling
Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas
title Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas
title_full Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas
title_fullStr Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas
title_full_unstemmed Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas
title_short Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas
title_sort clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large b-cell lymphomas
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265495/
https://www.ncbi.nlm.nih.gov/pubmed/25465716
http://dx.doi.org/10.1186/1471-2407-14-900
work_keys_str_mv AT wuhuanwen clinicalcharacteristicsandprognosticfactorsofbonelymphomasfocusontheclinicalsignificanceofmultifocalboneinvolvementbyprimarybonelargebcelllymphomas
AT buimarilynm clinicalcharacteristicsandprognosticfactorsofbonelymphomasfocusontheclinicalsignificanceofmultifocalboneinvolvementbyprimarybonelargebcelllymphomas
AT lestondouglasg clinicalcharacteristicsandprognosticfactorsofbonelymphomasfocusontheclinicalsignificanceofmultifocalboneinvolvementbyprimarybonelargebcelllymphomas
AT shaohaipeng clinicalcharacteristicsandprognosticfactorsofbonelymphomasfocusontheclinicalsignificanceofmultifocalboneinvolvementbyprimarybonelargebcelllymphomas
AT sokollubomir clinicalcharacteristicsandprognosticfactorsofbonelymphomasfocusontheclinicalsignificanceofmultifocalboneinvolvementbyprimarybonelargebcelllymphomas
AT sotomayoreduardom clinicalcharacteristicsandprognosticfactorsofbonelymphomasfocusontheclinicalsignificanceofmultifocalboneinvolvementbyprimarybonelargebcelllymphomas
AT zhangling clinicalcharacteristicsandprognosticfactorsofbonelymphomasfocusontheclinicalsignificanceofmultifocalboneinvolvementbyprimarybonelargebcelllymphomas